RhinoCyte
Latest round
- Series A
Last raised
- Jul 2014
Total raised
- $2.2M
Investors
- 3
About RhinoCyte
Based in the US, RhinoCyte Inc. develops a breakthrough technology engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases.
Who invested in RhinoCyte
3 investors across 2 rounds
See all investors in RhinoCyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RhinoCyte
Who invested in RhinoCyte?
RhinoCyte has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RhinoCyte raised?
RhinoCyte has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RhinoCyte last raise money?
RhinoCyte's most recent round on record is a Series A, in Jul 2014.
What does RhinoCyte do?
Based in the US, RhinoCyte Inc.
Where is RhinoCyte headquartered?
RhinoCyte is headquartered in Louisville, US.
Which VCs invest in companies like RhinoCyte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RhinoCyte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RhinoCyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.